Study identifies enzymes needed to mend tissue damage after inflammation
Findings may help predict colon cancer risk for patients with inflammatory bowel disease.
Findings may help predict colon cancer risk for patients with inflammatory bowel disease.
New MIT study offers comprehensive look at chemical and genetic changes that occur as inflammation progresses to cancer.
Pared-down nucleic acid nanoparticle poses less risk of side effects, offers better targeting.
New MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.
Tiny particles could manufacture cancer drugs at tumor sites.
Tiny particles designed to home in on cancer cells achieve tumor shrinkage at lower doses than traditional chemotherapy.
Killian Award recipient JoAnne Stubbe says some free radicals can be good for you.
Institutions, research teams, non-profit organizations join forces in novel approaches targeting pancreatic cancer, glioblastoma.
New RNA interference method holds promise for treating cancer, other diseases.
New microfluidic device could be used to diagnose and monitor cancer and other diseases.
By swapping microbial genes, Chris Voigt designs cells with novel functions.
New study could explain why variant enzymes boost the risk of cancer for some people.
Imaging technology could help researchers test new drugs for treating brain cancer.
New study shows that tumor cells, deprived of glucose, alter their metabolism to use other sources of sustenance.